Heart Rhythm
Volume 5, Issue 5 , Pages 670-676, May 2008

High Amplitude T-wave Alternans Precedes Spontaneous Ventricular Tachycardia or Fibrillation in ICD Electrograms

Cedars Sinai Medical Center, Los Angeles, CA Medtronic Inc., Minneapolis, MN

Received 13 October 2007; accepted 6 February 2008. published online 18 February 2008.

Background

T-wave alternans (TWA) increases acutely prior to ventricular tachycardia (VT) or fibrillation (VF) in animal studies, suggesting that it may provide a warning for VT/VF in implantable cardioverter defibrillator (ICD) patients. Clinically, measurement of surface ECG TWA requires preprocessing the input signal to reduce noise and/or analyzing more sinus beats than are recorded in ICDs as pre-onset, stored intracardiac electrograms (EGMs) before VT/VF. Our objective was to measure TWA from the few sinus EGMs stored in ICDs before spontaneous VT/VF in humans.

Objective

The purpose of this study was to evaluate the technical feasibility of measuring TWA from pre-onset ICD EGMs and to measure EGM TWA before spontaneous VT/VF in humans.

Methods

We developed a method to measure EGM TWA as a simple average (AVE) of peak-to-peak alternans. Using simulation, we determined the effect of ICD signal processing on EGM TWA for durations comparable to those in pre-onset EGMs. We then applied this method to pre-onset ICD EGMs that preceded 101 episodes of sustained VT/VF in 10 patients. In 6 of these patients, EGM recordings in atrial pacing and sinus rhythm provided control data.

Results

In simulation, the AVE method discriminated input TWA differences ≥ 15 μV. In patients, EGM TWA was 78 ± 62 μV prior to VT/VF vs. 13 ± 10 μV in control recordings (p< .0001). Eighty percent of pre-onset measurements exceeded 30 μV, while 95% of control measurements were less than 30 μV.

Conclusions

A simple averaging method can measure TWA preceding VT/VF in stored ICD EGMs. Pilot data indicate that high-amplitude EGM TWA usually precedes spontaneous VT/VF and is infrequent in control recordings. They provide a rationale for developing ICD technology to measure EGM TWA continuously, both to warn patients and to initiate pacing algorithms to prevent VT/VF.

Keywords: Tachyarrhythmias, T-wave alternans, Implantable cardioverter defibrillator

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Financial Support: No financial support was provided for this study.

 Potential Conflict of Interest: Dr. Swerdlow is a consultant to Medtronic. Mr. Zhou, Mr. Abeyratne, and Mr. Gillberg are employees of Medtronic.

PII: S1547-5271(08)00142-2

doi:10.1016/j.hrthm.2008.02.018

Heart Rhythm
Volume 5, Issue 5 , Pages 670-676, May 2008